Finance

Lists
ADPT:NASDAQ
Adaptive Biotechnologies Corp
28,87 $
+1,26%
(+0,36) 1D
29 սեպ, 14:20:52 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ADPT...
Open
29,28 $
High
29,80 $
Low
28,63 $
Mkt. cap
4,61 մլրդ
Avg. vol.
2,12 մլն
Volume
1,29 մլն
52-wk high
29,96 $
52-wk low
12,00 $
EPS
-0,41 $
Beta
2,09
Shares outstanding
159,60 մլն
No. of employees
624
Open
29,28 $
High
29,80 $
Low
28,63 $
Mkt. cap
4,61 մլրդ
Avg. vol.
2,12 մլն
Volume
1,29 մլն
52-wk high
29,96 $
52-wk low
12,00 $
EPS
-0,41 $
Beta
2,09
Shares outstanding
159,60 մլն
No. of employees
624
News stories
From web sources and news partners
About Adaptive Biotechnologies Corp
CEOChad Robins
Employees624
Founded2009
HeadquartersՍիեթլ, Վաշինգտոն, Միացյալ Նահանգներ
Sector-
Websiteadaptivebiotech.com
Analyst ratings
Based on 9 analysts giving stock ratings to ADPT in the past 3 months
Strong buy
Buy
8
Hold
1
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for ADPT in the last 3 months.
Highest
Current 28,87 $
35,00 $ (+21,23%)
Average
28,36 $ (-1,77%)
Lowest
22,00 $ (-23,80%)
Analyst
Recommendation
Action
Price target
Projected
Date
Evie Koslosky
Goldman Sachs
Buy
Initiated
35,00 $
+21,2%
09/29/2026
Mark Massaro
BTIG
Buy
Reiterated
34,00 $
+17,8%
09/22/2026
William Bonello
Craig-Hallum
Buy
Maintained
-
-
09/17/2026
David Westenberg
Piper Sandler
Buy
Maintained
27,50 $
-4,7%
08/24/2026
Sebastian Sandler
J.P. Morgan
Buy
Maintained
27,00 $
-6,5%
07/30/2026
Kallum Titchmarsh
Morgan Stanley
Hold
Maintained
22,00 $
-23,8%
07/30/2026
Subbu Nambi
Guggenheim
Buy
Reiterated
25,00 $
-13,4%
07/29/2026
Matt Larew
William Blair
Buy
Maintained
-
-
07/30/2026
Daniel Brennan
TD Cowen
Buy
Reiterated
28,00 $
-3%
07/30/2026
Andrew Brackmann
William Blair
Buy
Reiterated
-
-
06/16/2026
Last report
29 հլս, 2026 թ.
Fiscal period
Q2 2026
EPS / Est. (USD)
-0,25 $ / -0,13 $
-87,20%miss
Revenue / Est. (USD)
71,55 մլն / 65,45 մլն
+9,32%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
93,97 մլն
71,68 մլն
70,87 մլն
71,55 մլն
Cost of goods sold
41,83 մլն
39,99 մլն
42,33 մլն
39,32 մլն
Cost of revenue
41,83 մլն
39,99 մլն
42,33 մլն
39,32 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
41,43 մլն
44,04 մլն
47,33 մլն
47,58 մլն
Operating expense
41,86 մլն
44,47 մլն
47,75 մլն
48,00 մլն
Total operating expenses
83,68 մլն
84,45 մլն
90,08 մլն
87,32 մլն
Operating income
10,29 մլն
-12,77 մլն
-19,21 մլն
-15,77 մլն
Other non operating income
-
-
-
-
EBT including unusual items
9,54 մլն
-13,58 մլն
-20,02 մլն
-39,94 մլն
EBT excluding unusual items
9,54 մլն
-13,87 մլն
-20,15 մլն
-16,21 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
9,55 մլն
-13,58 մլն
-20,03 մլն
-39,79 մլն
Net profit margin
10,16%
-18,94%
-28,27%
-55,61%
Earnings per share
0,06
-0,09
-0,13
-0,25
Interest and investment income
2,23 մլն
1,86 մլն
1,94 մլն
2,26 մլն
Interest expense
-2,97 մլն
-2,95 մլն
-2,89 մլն
-2,69 մլն
Net interest expenses
-745,00 հզր
-1,09 մլն
-945,00 հզր
-438,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
14,70 մլն
-8,58 մլն
-15,37 մլն
-12,08 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps